Oral-Systemic Link: Page 61

Study: Cause of periodontitis related to type 2 diabetes
By DrBicuspid.com staff writers
Modulating the responses of B cells in blood cells may effectively treat or prevent the symptoms of type 2 diabetes and periodontitis simultaneously, according to a new study in the Journal of Leukocyte Biology.
July 31, 2014
Study: Diabetes increases risk for head and neck cancer
By Donna Domino
The risk for head and neck cancer was almost 50% higher in patients with diabetes mellitus than in individuals without diabetes in a new study in JAMA Otolaryngology -- Head & Neck Surgery. The estimated risk for head and neck cancer was also higher for male patients and people ages 40 to 65.
July 31, 2014
2013 05 02 13 20 25 544 Diabetes 200
Quick, low-cost blood test detects early signs of oral cancer
By DrBicuspid.com staff writers
Australian researchers have developed a quick, low-cost blood test to detect the early signs of oral cancer. The test examines the profile of microRNA in the blood and can be done along with routine checks, such as for cholesterol.
July 30, 2014
2013 04 10 10 14 48 506 Cancer Cell 200
Forward Science donates OralID to NC Missions of Mercy
By DrBicuspid.com staff writers
Forward Science Technologies, the developer of OralID and CytID, recently awarded an OralID device to North Carolina Missions of Mercy (NCMOM).
July 28, 2014
Zilico gets funding to develop device to detect oral cancer
By DrBicuspid.com staff writers
Medical products developer Zilico has secured funding to develop a new device that detects oral cancer.
July 24, 2014
Antipain agent shrinks oral cancers without damaging healthy tissue
By DrBicuspid.com staff writers
Mouse models of human oral cancer treated with capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, according to a study in Oral Oncology. Capsazepine's anticancer effects may stem from its ability to increase oxidative damage in tumors, Texas researchers said.
July 24, 2014
2013 04 10 10 14 48 506 Cancer Cell 200
Advaxis, MedImmune partner on clinical trial
By DrBicuspid.com staff writers
Advaxis, a biotechnology company that develops cancer immunotherapies, has entered a clinical trial collaboration with MedImmune, the biologics research and development arm of AstraZeneca.
July 21, 2014
Propofol + nitrous oxide may avoid sedation hypotension
By Rob Goszkowski
Hypotension is a risk associated with the administration of propofol. Now Japanese researchers have found that combining it with nitrous oxide leads to better sedation and smaller reduction of blood pressure.
July 21, 2014
2014 07 21 16 18 37 990 Human Heart 200
Oral Cancer Foundation, Cody Kiser partner for Idaho rodeo
By DrBicuspid.com staff writers
The Oral Cancer Foundation is partnering with Cody Kiser, a rodeo cowboy who will serve as a spokesman for the group, at the Snake River Stampede Rodeo, held July 15-19 in Nampa, ID.
July 16, 2014
DrBicuspid.com Oral Cancer & Diagnostics Insider
By Donna Domino
July 16, 2014
Study finds link between perio disease, atherosclerosis
By DrBicuspid.com staff writers
Chronic oral infection with the periodontal disease pathogen Porphyromonas gingivalis not only causes local inflammation of the gums leading to tooth loss but is also associated with an increased risk of atherosclerosis, according to a study in PLOS Pathogens.
July 14, 2014
Oral piercings; genetic testing for oral cancer; diode lasers in periodontal therapy
By Tony Edwards
July 1, 2014
Previous Page
Page 61 of 153
Next Page